MSB 4.66% $1.46 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-845

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,445 Posts.
    lightbulb Created with Sketch. 766
    Silviu has 20 sales staff already and gearing up big time for increases in production accordingly.

    Are you suggesting he has less idea about the FDA approving the manufacturing process quickly... or already in the bag.... then you? Silviu has talked with them how many times?..... And you....?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.46
Change
0.065(4.66%)
Mkt cap ! $1.667B
Open High Low Value Volume
$1.41 $1.50 $1.40 $5.699M 3.943M

Buyers (Bids)

No. Vol. Price($)
5 122380 $1.46
 

Sellers (Offers)

Price($) Vol. No.
$1.46 11015 2
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.